These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1821223)

  • 1. The measurement of aggressive behavior: reflections on the use of the Overt Aggression Scale and the Modified Overt Aggression Scale.
    Ratey JJ; Gutheil CM
    J Neuropsychiatry Clin Neurosci; 1991; 3(2):S57-60. PubMed ID: 1821223
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of the Carolina Nosology of Destructive Behavior.
    Eichelman B; Hartwig A
    J Neuropsychiatry Clin Neurosci; 1991; 3(2):S15-21. PubMed ID: 1821216
    [No Abstract]   [Full Text] [Related]  

  • 3. Rating aggression in the clinical setting. A retrospective adaptation of the Overt Aggression Scale: preliminary results.
    Sorgi P; Ratey J; Knoedler DW; Markert RJ; Reichman M
    J Neuropsychiatry Clin Neurosci; 1991; 3(2):S52-6. PubMed ID: 1687961
    [No Abstract]   [Full Text] [Related]  

  • 4. Nadolol to treat aggression and psychiatric symptomatology in chronic psychiatric inpatients: a double-blind, placebo-controlled study.
    Ratey JJ; Sorgi P; O'Driscoll GA; Sands S; Daehler ML; Fletcher JR; Kadish W; Spruiell G; Polakoff S; Lindem KJ
    J Clin Psychiatry; 1992 Feb; 53(2):41-6. PubMed ID: 1347291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can aggressive behavior in humans be modified by beta blockers?
    Volavka J
    Postgrad Med; 1988 Feb; Spec No():163-8. PubMed ID: 2894657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nadolol in the treatment of aggression in chronic psychiatric inpatients.
    Wong MK; Lee S
    J Clin Psychiatry; 1993 Jun; 54(6):235. PubMed ID: 8331093
    [No Abstract]   [Full Text] [Related]  

  • 7. Nadolol in the treatment of aggressive behavior associated with schizophrenia.
    Ritrovato CA; Weber SS; Dufresne RL
    Clin Pharm; 1989 Feb; 8(2):132-5. PubMed ID: 2917450
    [No Abstract]   [Full Text] [Related]  

  • 8. The measurement of self-injurious behavior.
    Gualtieri CT
    J Neuropsychiatry Clin Neurosci; 1991; 3(2):S30-4. PubMed ID: 1821219
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic effects of pindolol on behavioral disturbances associated with organic brain disease: a double-blind study.
    Greendyke RM; Kanter DR
    J Clin Psychiatry; 1986 Aug; 47(8):423-6. PubMed ID: 3525523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aggressive behavior in the psychiatric clinic].
    Genz A; Krüger E; Dost B
    Psychiatr Neurol Med Psychol (Leipz); 1988 Sep; 40(9):542-50. PubMed ID: 3237883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of violent behavior among acute psychiatric patients: clinical study.
    Amore M; Menchetti M; Tonti C; Scarlatti F; Lundgren E; Esposito W; Berardi D
    Psychiatry Clin Neurosci; 2008 Jun; 62(3):247-55. PubMed ID: 18588583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic management of aggression in the elderly.
    Yudofsky SC; Silver JM; Hales RE
    J Clin Psychiatry; 1990 Oct; 51 Suppl():22-8; discussion 29-32. PubMed ID: 1976621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-aggressive effect of beta-blockers].
    Thibaut F; Colonna L
    Encephale; 1993; 19(3):263-7. PubMed ID: 7903928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggression and psychopathology in treatment-resistant inpatients with schizophrenia and schizoaffective disorder.
    Nolan KA; Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome LL; McEvoy J; Lieberman JA
    J Psychiatr Res; 2005 Jan; 39(1):109-15. PubMed ID: 15504429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Overt Aggression Scale: overview and guiding principles.
    Silver JM; Yudofsky SC
    J Neuropsychiatry Clin Neurosci; 1991; 3(2):S22-9. PubMed ID: 1821217
    [No Abstract]   [Full Text] [Related]  

  • 16. [Differential diagnosis of aggressive behavior in epilepsy].
    Steinert T; Fröscher W
    Psychiatr Prax; 1995 Jan; 22(1):15-8. PubMed ID: 7892336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Violence among schizophrenia out-patients compliant with medication: prevalence and associated factors.
    Bobes J; Fillat O; Arango C
    Acta Psychiatr Scand; 2009 Mar; 119(3):218-25. PubMed ID: 19178395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ethnic minorities and aggressive behaviour in psychiatric in-patients: an investigation using a "Matched-Pair" design].
    Grube M
    Psychiatr Prax; 2004 Jan; 31(1):11-5. PubMed ID: 14727193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled study of adjunctive nadolol in the management of violent psychiatric patients.
    Alpert M; Allan ER; Citrome L; Laury G; Sison C; Sudilovsky A
    Psychopharmacol Bull; 1990; 26(3):367-71. PubMed ID: 2274638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic approaches to violence.
    Conn LM; Lion JR
    Psychiatr Clin North Am; 1984 Dec; 7(4):879-86. PubMed ID: 6151653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.